๐๐ข๐ญ๐ฌ๐ฎ๐ข ๐๐ก๐๐ฆ๐ข๐๐๐ฅ๐ฌ ๐๐ง๐ฏ๐๐ฌ๐ญ๐ฌ ๐ข๐ง ๐๐๐ญ๐๐ซ๐ข๐ ๐๐ข๐จ๐ฐ๐จ๐ซ๐ค๐ฌ
Mitsui Chemicals, Inc. announced today that it has made a minority investment in Materia Bioworks Inc. through 321Catalyst™, its corporate venture capital (CVC) fund.
#MateriaBioworks is a startup utilizing computational chemistry and AI to develop a platform (“MAPS”) that can efficiently design and formulate sustainable materials, such as #bioplastics. By leveraging computational chemistry and AI, the company streamlines product development using bioplastics, a process that traditionally required significant time and cost, thereby reducing development time and costs while also driving down the cost of bioplastics themselves.
Purpose of the Investment
By utilizing their biomass materials in Materia Bioworks’ bioplastic design services, #MitsuiChemicals aims to expand its provision of bioplastic materials offering to customers globally. Furthermore, Mitsui Chemicals will collaborate with Materia Bioworks to meet the performance and quality requirements of customers through the possible joint development of new bioplastic materials.
source : Mitsui Chemicals

Comments
Post a Comment